Showing results (181-190 of 267) with videos related to

Sort By:
Pageof 27
Bone Marrow Transplantation|June 29, 2026
T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMTSarah Kayser, Arnon Nagler, Allain Thibeault Ferhat, et al.
Bone Marrow Transplantation|April 24, 2025
Cytokine release syndrome: implications for transplant outcomes in haploidentical and HLA-matched HSCT using PTCyRafael Benavente, Juan Montoro, Aitana Balaguer-Roselló, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2009
Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantationPau Montesinos, Jaime Sanz, Susana Cantero, et al.
Leukemia & Lymphoma|July 14, 2020
Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxisMaría Laura Fox, Irene García-Cadenas, Ariadna Martínez Pérez, et al.
Journal of Hematology & Oncology|July 5, 2020
Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donorsEolia Brissot, Myriam Labopin, Ian Moiseev, et al.
Haematologica|August 18, 2025
Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationJaime Sanz, Allain-Thibeault Ferhat, Alexander Kulagin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2011
Significance of increased blastic-appearing cells in bone marrow following myeloablative unrelated cord blood transplantation in adult patientsPau Montesinos, Adriana Gascón, David Martínez-Cuadrón, et al.
Transplantation and Cellular Therapy|August 28, 2022
Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid LeukemiaArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Annals of Hematology|November 3, 2020
Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantationRebeca Bailén, Mi Kwon, María Jesús Pascual-Cascón, et al.
Bone Marrow Transplantation|February 5, 2025
The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamideAlexandros Spyridonidis, Myriam Labopin, Bipin P Savani, et al.
Pageof 27